FDA grants tentative approval for generic version of Zyprexa

Alaric DeArment

12/1/2008

ROCKVILLE, Md. The Food and Drug Administration has granted tentative approval to Roxane Labs’ generic version of Eli Lilly and Co.’s antipsychotic drug, Zyprexa, FDA records show.

The FDA passed tentative approval for the generic version of the drug in the 5 mg strength Nov. 20.

Several other drug makers, such as Teva, Mylan, Sandoz and Barr Labs, also are developing generic versions of Zyprexa.

CVS Weight Management program improves health outcomes, lowers costs

As of Feb. 1, the CVS Weight Management program is available to more than 3.5 million CVS Caremark plan members.

CVS Health to open smaller format stores

Each location will average less than 5,000 square feet and will feature a full-service pharmacy with limited over-the-counter products available for purchase.

Meijer to open 3 new Northeast Ohio Supercenters

The new stores in Austintown, Medina and Richmond Heights increase the retailer's store count to 58 in Ohio.

Walgreens buyout reportedly could result in three divisions

Walgreens’ three core segments—U.S. pharmacy retailer Walgreens, U.K.-based Boots and specialty unit Shields Health Solutions—could become three independent divisions, per a report.

Kiss Products unveils ‘Wicked’-inspired nail, lash collection

The collection includes lashes and nails from Kiss Nails, imPress Nails, Falscara and imPress Faslsies lines.